par Wyndham-Thomas, Chloe
;Dirix, Violette
;Schepers, Kinda
;Martin, Charlotte
;Hildebrand, Marc;Goffard, Jean-Christophe
;Domont, Fanny;Libin, Myriam
;Loyens, Marc;Locht, Camille
;Van Vooren, Jean-Paul
;Mascart, Françoise 
Référence BMC infectious diseases, 15, page (59)
Publication Publié, 2015









Référence BMC infectious diseases, 15, page (59)
Publication Publié, 2015
Article révisé par les pairs
Résumé : | The screening and treatment of latent tuberculosis (TB) infection reduces the risk of progression to active disease and is currently recommended for HIV-infected patients. The aim of this study is to evaluate, in a low TB incidence setting, the potential contribution of an interferon-gamma release assay in response to the mycobacterial latency antigen Heparin-Binding Haemagglutinin (HBHA-IGRA), to the detection of Mycobacterium tuberculosis infection in HIV-infected patients. |